OnKure Therapeutics Files 8-K on Security Holder Vote & Financials
Ticker: OKUR · Form: 8-K · Filed: May 28, 2025 · CIK: 1637715
Sentiment: neutral
Topics: 8-K, regulatory-filing, corporate-governance
TL;DR
OnKure Therapeutics (OKUR) filed an 8-K for shareholder votes and financials.
AI Summary
On May 27, 2025, OnKure Therapeutics, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The company, formerly known as Reneo Pharmaceuticals, Inc., is incorporated in Delaware and headquartered in Boulder, Colorado.
Why It Matters
This filing indicates that OnKure Therapeutics is proceeding with corporate actions requiring shareholder approval and is providing necessary financial disclosures, which are standard procedures for public companies.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain new material information that would inherently increase risk.
Key Numbers
- 001-40315 — SEC File Number (Identifies the company's filing history with the SEC.)
- 47-2309515 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- OnKure Therapeutics, Inc. (company) — Registrant
- Reneo Pharmaceuticals, Inc. (company) — Former Company Name
- May 27, 2025 (date) — Date of earliest event reported
- Boulder, Colorado (location) — Principal Executive Offices
FAQ
What specific matters are being submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.
What financial statements are being filed?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in this excerpt.
When was OnKure Therapeutics, Inc. formerly known as Reneo Pharmaceuticals, Inc.?
The date of the name change from Reneo Pharmaceuticals, Inc. to OnKure Therapeutics, Inc. was March 25, 2015.
Where are OnKure Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 6707 Winchester Circle, #400, Boulder, Colorado 80301.
What is the company's standard industrial classification?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding OnKure Therapeutics, Inc. (OKUR).